I Maurer

Summary

Affiliation: Friedrich Schiller University
Country: Germany

Publications

  1. ncbi request reprint Gabapentin leads to remission of somatoform pain disorder with major depression
    I Maurer
    Department of Psychiatry, Friedrich Schiller Universitat Jena, Germany
    Pharmacopsychiatry 32:255-7. 1999
  2. ncbi request reprint A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
    I Maurer
    Department of Psychiatry, Friedrich Schiller Universitat, Philosophenweg 3, 07740, Jena, Germany
    Neurobiol Aging 21:455-62. 2000
  3. ncbi request reprint Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia
    I Maurer
    Department of Psychiatry, Friedrich Schiller Universitat, Philosophenweg 3, 07740, Jena, Germany
    Schizophr Res 48:125-36. 2001
  4. ncbi request reprint Cell-mediated side effects of psychopharmacological treatment
    I Maurer
    Psychiatric Department, Friedrich Schiller University of Jena, Jena, Germany
    Arzneimittelforschung 51:785-92. 2001
  5. ncbi request reprint Requestioning depression in patients with cancer: contribution of somatic and affective symptoms to Beck's Depression Inventory
    U Wedding
    Department of Haematology and Medical Oncology, Friedrich Schiller University, Jena, Germany
    Ann Oncol 18:1875-81. 2007
  6. ncbi request reprint Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans
    U D Kuhn
    Institute of Clinical Pharmacology, Friedrich Schiller University, Jena, Germany
    Int J Clin Pharmacol Ther 45:36-46. 2007

Detail Information

Publications6

  1. ncbi request reprint Gabapentin leads to remission of somatoform pain disorder with major depression
    I Maurer
    Department of Psychiatry, Friedrich Schiller Universitat Jena, Germany
    Pharmacopsychiatry 32:255-7. 1999
    ..Antidepressants and carbamazepine were ineffective, and she had attempted suicide. Gabapentin resulted in remission of both the pain and the depressive mood at a dose of 1.800 mg/day...
  2. ncbi request reprint A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients
    I Maurer
    Department of Psychiatry, Friedrich Schiller Universitat, Philosophenweg 3, 07740, Jena, Germany
    Neurobiol Aging 21:455-62. 2000
    ..Biochemically, the defect is confined to selected brain regions, suggesting anatomic specificity...
  3. ncbi request reprint Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia
    I Maurer
    Department of Psychiatry, Friedrich Schiller Universitat, Philosophenweg 3, 07740, Jena, Germany
    Schizophr Res 48:125-36. 2001
    ..All other enzyme activities showed no differences to healthy controls. The results confirm a defect of oxidative phosphorylation in brains from patients with schizophrenia, which may contribute to impaired energy generation...
  4. ncbi request reprint Cell-mediated side effects of psychopharmacological treatment
    I Maurer
    Psychiatric Department, Friedrich Schiller University of Jena, Jena, Germany
    Arzneimittelforschung 51:785-92. 2001
    ..Neuroleptics might then be developed that are effectively antipsychotic but are less likely to produce limiting extrapyramidal side effects...
  5. ncbi request reprint Requestioning depression in patients with cancer: contribution of somatic and affective symptoms to Beck's Depression Inventory
    U Wedding
    Department of Haematology and Medical Oncology, Friedrich Schiller University, Jena, Germany
    Ann Oncol 18:1875-81. 2007
    ..Depressive symptoms are a major complaint reported by cancer patients. Somatic and affective symptoms can contribute to depression...
  6. ncbi request reprint Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans
    U D Kuhn
    Institute of Clinical Pharmacology, Friedrich Schiller University, Jena, Germany
    Int J Clin Pharmacol Ther 45:36-46. 2007
    ..Thus, in this study the pharmacokinetics of reboxetine in relation to pharmacogenetics and the effects of reboxetine compared to paroxetine treatment on the CYP2D6 and CYP3A4 phenotype were analyzed in healthy control subjects...